Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 319 followers

Latest posts

Last updated about 3 hours ago

Annual report on the use of the special contribution for orphan medicinal products - 2025

about 3 hours ago

Annual report on the use of the special contribution for orphan medicinal...

Questions and answers on the use of out-of-specification batches of authorised cell and tissue-based advanced therapy medicinal products

about 3 hours ago

Questions and answers on the use of out-of-specification batches of authorised cell...

Consolidated 3-year work plan for the clinical domain

about 3 hours ago

Consolidated 3-year work plan for the clinical domain

Scientific advice and protocol assistance adopted during the CHMP meeting 23-26 February 2026

about 4 hours ago

Scientific advice and protocol assistance adopted during the CHMP meeting 23-26 February...

Medicines for human use under evaluation

about 4 hours ago

Medicines for human use under evaluation

EMA/PE/0000228283

about 4 hours ago

EMA/PE/0000228283

Human medicines European public assessment report (EPAR): Afqlir, aflibercept, Date of authorisation: 13/11/2024, Revision: 6, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Afqlir, aflibercept, Date of authorisation...

EMA/PE/0000226753

about 5 hours ago

EMA/PE/0000226753

Human medicines: highlights of 2022

about 5 hours ago

Human medicines: highlights of 2022

Human medicines highlights 2022

about 5 hours ago

Human medicines highlights 2022

Human medicines European public assessment report (EPAR): Zeposia, ozanimod, Date of authorisation: 20/05/2020, Revision: 11, Status: Authorised

about 5 hours ago

Human medicines European public assessment report (EPAR): Zeposia, ozanimod, Date of authorisation...